Vitamin D decreases pain in women with type 2 diabetes and depression, according to a study conducted at Loyola University Chicago. These findings were presented at an Oct. 24, 2013 research conference at Loyola’s Health Sciences Campus.
Type 2 diabetes is associated with depression and pain, but few studies have looked at how pain may affect the treatment of depression in patients with type 2 diabetes and no studies have evaluated the role of vitamin D supplementation on this association.
Researchers in this study tested the efficacy of weekly vitamin D2 supplementation (50,000 IUs) for six months on depression in women with type 2 diabetes. Depression significantly improved following supplementation. In addition, 61 percent of patients reported shooting or burning pain in their legs and feet (neuropathic pain) and 74 percent reported numbness and tingling in their hands, fingers, and legs (sensory pain) at the beginning of the study. Researchers found a significant decrease in neuropathic and sensory pain at three and six months following vitamin D2 supplementation.
“Pain is a common and often serious problem for women with type 2 diabetes and depression,” said Todd Doyle, PhD, lead author and fellow, Department of Psychiatry & Behavioral Neurosciences, Loyola University Chicago Stritch School of Medicine (SSOM). “While further research is needed, D2 supplementation is a promising treatment for both pain and depression in type 2 diabetes.”
Loyola researchers have received funding from the National Institute of Nursing Research to conduct a trial comparing the effects of two different doses of vitamin D3 supplements on health outcomes in women with diabetes.
“Vitamin D has widespread benefits for our health and certain chronic diseases such as type 2 diabetes,” said Sue Penckofer, PhD, RN, study co-author and professor, Loyola University Chicago Marcella Niehoff School of Nursing. “This NIH grant will allow us to shed greater light on understanding the role that this nutrient plays in managing the health of women with diabetes.”
Other study authors included Patricia Mumby, PhD, professor, Department of Psychiatry & Behavioral Neurosciences, Mary Anne Emanuele, MD, professor, Department of Endocrinology & Metabolism, SSOM; Mary Alice Byrn, PhD, assistant professor, Department of Nursing, St. Mary’s College, Notre Dame, Ind.; and Diane E. Wallis, MD, Midwest Heart Specialists, Downers Grove, Ill.
The Loyola University Chicago Health Sciences Division (HSD) advances interprofessional, multidisciplinary, and transformative education and research while promoting service to others through stewardship of scientific knowledge and preparation of tomorrow's leaders. The HSD is located on the Health Sciences Campus in Maywood, Illinois.
It includes the Marcella Niehoff School of Nursing, the Stritch School of Medicine, the biomedical research programs of the Graduate School, and several other institutes and centers encouraging new research and interprofessional education opportunities across all of Loyola University Chicago. The faculty and staff of the HSD bring a wealth of knowledge, experience, and a strong commitment to seeing that Loyola's health sciences continue to excel and exceed the standard for academic and research excellence. For more on the HSD, visit LUC.edu/hsd.
Nora Dudley | EurekAlert!
Study suggests possible new target for treating and preventing Alzheimer's
02.12.2016 | Oregon Health & Science University
The first analysis of Ewing's sarcoma methyloma opens doors to new treatments
01.12.2016 | IDIBELL-Bellvitge Biomedical Research Institute
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
02.12.2016 | Medical Engineering
02.12.2016 | Agricultural and Forestry Science
02.12.2016 | Physics and Astronomy